Bioinformatic analysis of the origin, sequence and diversification of μ opioid receptors in vertebrates

Molecular Phylogenetics and Evolution

Volumn 49, Issue 3, 2008, Pages 877-892

  Herrero Turrion, M Javier ^a   Rodríguez, Raquel E ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Opioid receptor; Bioinformatics; Comparative genomics; Evolution

Indexed keywords

MU OPIATE RECEPTOR;

ANIMAL; ARTICLE; BIOLOGY; COMPARATIVE STUDY; GENETIC DATABASE; GENETICS; GENOMICS; MOLECULAR EVOLUTION; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SYNTENY; VERTEBRATE;

ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; EVOLUTION, MOLECULAR; GENOMICS; PHYLOGENY; RECEPTORS, OPIOID, MU; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; SYNTENY; VERTEBRATES;

TELEOSTEI; VERTEBRATA;

EID: 56549110873     PISSN: 10557903     EISSN: 10959513     Source Type: Journal    
DOI: 10.1016/j.ympev.2008.09.016     Document Type: Article

References (86)

1. Adoutte A., Balavoine G., Lartillot N., Lespinet O., Prud'homme B., and de R.R. The new animal phylogeny: reliability and implications. Proc. Natl. Acad. Sci. USA 97 (2000) 4453-4456
2. Alvarez F.A., Rodriguez-Martin I., Gonzalez-Nunez V., de Velasco E.M., Gonzalez S.R., and Rodriguez R.E. New kappa opioid receptor from zebrafish Danio rerio. Neurosci. Lett. 405 (2006) 94-99
3. Babushok D.V., Ostertag E.M., and Kazazian Jr. H.H. Current topics in genome evolution: molecular mechanisms of new gene formation. Cell Mol. Life Sci. 64 (2007) 542-554
4. Barrallo A., Gonzalez-Sarmiento R., Alvar F., and Rodriguez R.E. ZFOR2, a new opioid receptor-like gene from the teleost zebrafish (Danio rerio). Brain Res. Mol. Brain Res. 84 (2000) 1-6
5. Barrallo A., Malvar F.G., Gonzalez R., Rodriguez R.E., and Traynor J.R. Cloning and characterization of a delta opioid receptor from zebrafish. Biochem. Soc. Trans. 26 (1998) S360
6. Bot G., Blake A.D., Li S., and Reisine T. Mutagenesis of a single amino acid in the rat Mu-opioid receptor discriminates ligand binding. J. Neurochem. 70 (1998) 358-365
7. Bradford C.S., Walthers E.A., Searcy B.T., and Moore F.L. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa. J. Mol. Endocrinol. 34 (2005) 809-823
8. Bradford C.S., Walthers E.A., Stanley D.J., Baugh M.M., and Moore F.L. Delta and Mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha Granulosa: Cloning, heterologous expression, and pharmacological characterization. Gen. Comp. Endocrinol. 146 (2006) 275-290
9. Burd A.L., El-Kouhen R., Erickson L.J., Loh H.H., and Law P.Y. Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the Mu-opioid receptor. J. Biol. Chem. 273 (1998) 34488-34495
10. Chaturvedi K., Christoffers K.H., Singh K., and Howells R.D. Structure and regulation of opioid receptors. Biopolymers 55 (2000) 334-346
11. Chaturvedi K., Shahrestanifar M., and Howells R.D. Mu opioid receptor: role for the amino terminus as a determinant of ligand binding affinity. Brain Res. Mol. Brain Res. 76 (2000) 64-72
12. Chavkin C., McLaughlin J.P., and Celver J.P. Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. Mol. Pharmacol. 60 (2001) 20-25
13. Chen Y., Mestek A., Liu J., Hurley J.A., and Yu L. Molecular cloning and functional expression of a Mu-opioid receptor from rat brain. Mol. Pharmacol. 44 (1993) 8-12
14. Claude P.A., Wotta D.R., Zhang X.H., Prather P.L., McGinn T.M., Erickson L.J., Loh H.H., and Law P.Y. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc. Natl. Acad. Sci. USA 93 (1996) 5715-5719
15. Darlison M.G., Greten F.R., Harvey R.J., Kreienkamp H.J., Stuhmer T., Zwiers H., Lederis K., and Richter D. Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated inward-rectifying potassium channel (GIRK1), and evolution. Proc. Natl. Acad. Sci. USA 94 (1997) 8214-8219
16. Dorus S., Vallender E.J., Evans P.D., Anderson J.R., Gilbert S.L., Mahowald M., Wyckoff G.J., Malcom C.M., and Lahn B.T. Accelerated evolution of nervous system genes in the origin of Homo Sapiens. Cell 119 (2004) 1027-1040
17. El Kouhen R., Burd A.L., Erickson-Herbrandson L.J., Chang C.Y., Law P.Y., and Loh H.H. Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates Mu-opioid receptor internalization. J. Biol. Chem. 276 (2001) 12774-12780
18. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39 (1985) 783-791
19. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 (2001) 1-24
20. Fowler C.B., Pogozheva I.D., LeVine III H., and Mosberg H.I. Refinement of a homology model of the Mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites. Biochemistry 43 (2004) 8700-8710
21. Fowler C.B., Pogozheva I.D., Lomize A.L., LeVine III H., and Mosberg H.I. Complex of an active Mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints. Biochemistry 43 (2004) 15796-15810
22. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol 63 (2003) 1256-1272
23. Fredriksson R., and Schioth H.B. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol. Pharmacol. 67 (2005) 1414-1425
24. Fukuda K., Kato S., and Mori K. Location of regions of the opioid receptor involved in selective agonist binding. J. Biol. Chem. 270 (1995) 6702-6709
25. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21 (2000) 90-113
26. Gloriam D.E., Fredriksson R., and Schioth H.B. The G protein-coupled receptor subset of the rat genome. BMC. Genomics 8 (2007) 338
27. Gonzalez-Nunez V., Barrallo A., Traynor J.R., and Rodriguez R.E. Characterization of opioid-binding sites in zebrafish brain. J. Pharmacol. Exp. Ther. 316 (2006) 900-904
28. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., and Bouvier M. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271 (1996) 16384-16392
29. Huang P., Li J., Chen C., Visiers I., Weinstein H., and Liu-Chen L.Y. Functional role of a conserved motif in TM6 of the rat Mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. Biochemistry 40 (2001) 13501-13509
30. Huang P., Visiers I., Weinstein H., and Liu-Chen L.Y. The local environment at the cytoplasmic end of TM6 of the Mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the Mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant. Biochemistry 41 (2002) 11972-11980
31. Josefsson L.G. Evidence for kinship between diverse G-protein coupled receptors. Gene 239 (1999) 333-340
32. Kane B.E., Svensson B., and Ferguson D.M. Molecular recognition of opioid receptor ligands. AAPS. J. 8 (2006) E126-E137
33. Kanematsu K., and Sagara T. An approach to the rational design of opioid receptor ligands: non-narcotic K-opioid receptor ligand KT-95 free from euphoria and/or dysphoria. Curr. Med. Chem. CNS Agents 1 (2001) 1-25
34. Katoh M. Paradigm shift in gene-finding method: from bench-top approach to desk-top approach (review). Int. J. Mol. Med. 10 (2002) 677-682
35. Krupnick J.G., and Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 289-319
36. Kyte J., and Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 154 (1982) 857-866
37. Lagerstrom M.C., Hellstrom A.R., Gloriam D.E., Larsson T.P., Schioth H.B., and Fredriksson R. The G protein-coupled receptor subset of the chicken genome. PLoS. Comput. Biol. 2 (2006) e54
38. Law P.Y., Loh H.H., and Wei L.N. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47 Suppl. 1 (2004) 300-311
39. Law P.Y., Wong Y.H., and Loh H.H. Mutational analysis of the structure and function of opioid receptors. Biopolymers 51 (1999) 440-455
40. Li X., Keith Jr. D.E., and Evans C.J. Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. FEBS Lett. 397 (1996) 25-29
41. Li X., Keith Jr. D.E., and Evans C.J. Mu opioid receptor-like sequences are present throughout vertebrate evolution. J. Mol. Evol. 43 (1996) 179-184
42. Mansour A., Taylor L.P., Fine J.L., Thompson R.C., Hoversten M.T., Mosberg H.I., Watson S.J., and Akil H. Key residues defining the Mu-opioid receptor binding pocket: a site-directed mutagenesis study. J. Neurochem. 68 (1997) 344-353
43. Mulder N.J., and Apweiler R. Tools and resources for identifying protein families, domains and motifs. Genome Biol. 3 (2002) 1-8
44. McPartland J.M., and Glass M. Functional mapping of cannabinoid receptor homologs in mammals, other vertebrates, and invertebrates. Gene 312 (2003) 297-303
45. McPartland J.M., Glass M., Matias I., Norris R.W., and Kilpatrick C.W. A shifted repertoire of endocannabinoid genes in the zebrafish (Danio rerio). Mol. Genet. Genomics 277 (2007) 555-570
46. Miller G.M., Bendor J., Tiefenbacher S., Yang H., Novak M.A., and Madras B.K. A Mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Mol. Psychiatry 9 (2004) 99-108
47. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse Mu opioid receptor gene. Proc. Natl. Acad. Sci. USA 91 (1994) 9081-9085
48. Minami M. Molecular pharmacology of opioid receptors. Nippon Yakurigaku Zasshi 123 (2004) 95-104
49. Minami M., and Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23 (1995) 121-145
50. Newman L.C., Sands S.S., Wallace D.R., and Stevens C.W. Characterization of Mu, Kappa, and Delta opioid binding in amphibian whole brain tissue homogenates. J. Pharmacol. Exp. Ther. 301 (2002) 364-370
51. Onogi T., Minami M., Katao Y., Nakagawa T., Aoki Y., Toya T., Katsumata S., and Satoh M. DAMGO, a Mu-opioid receptor selective agonist, distinguishes between Mu- and Delta-opioid receptors around their first extracellular loops. FEBS Lett. 357 (1995) 93-97
52. Onoprishvili I., Andria M.L., Vilim F.S., Hiller J.M., and Simon E.J. The bovine Mu-opioid receptor: cloning of CDNA and pharmacological characterization of the receptor expressed in mammalian cells. Brain Res. Mol. Brain Res. 73 (1999) 129-137
53. Pak Y., O'Dowd B.F., Wang J.B., and George S.R. Agonist-induced, G Protein-dependent and -independent down-regulation of the Mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase. J. Biol. Chem. 274 (1999) 27610-27616
54. Pampusch M.S., Osinski M.A., Brown D.R., and Murtaugh M.P. The porcine Mu opioid receptor: molecular cloning and MRNA distribution in lymphoid tissues. J. Neuroimmunol. 90 (1998) 192-198
55. Pan Y.X. diversity and complexity of the Mu opioid receptor gene: alternative pre-MRNA splicing and promoters. DNA Cell Biol. 24 (2005) 736-750
56. Pasternak G.W. Multiple opiate receptors: Deja Vu all over again. Neuropharmacology 47 Suppl. 1 (2004) 312-323
57. Pil J., and Tytgat J. The role of the hydrophilic Asn230 residue of the Mu-opioid receptor in the potency of various opioid agonists. Br. J. Pharmacol. 134 (2001) 496-506
58. Pinal-Seoane N., Martin I.R., Gonzalez-Nunez V., de Velasco E.M., Alvarez F.A., Sarmiento R.G., and Rodriguez R.E. Characterization of a new duplicate Delta-opioid receptor from zebrafish. J. Mol. Endocrinol. 37 (2006) 391-403
59. Pogozheva I.D., Lomize A.L., and Mosberg H.I. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. Biophys. J. 75 (1998) 612-634
60. Qiu Y., Law P.Y., and Loh H.H. Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J. Biol. Chem. 278 (2003) 36733-36739
61. Rodriguez R.E., Barrallo A., Garcia-Malvar F., McFadyen I.J., Gonzalez-Sarmiento R., and Traynor J.R. Characterization of ZFOR1, a putative Delta-opioid receptor from the teleost zebrafish (Danio rerio). Neurosci. Lett. 288 (2000) 207-210
62. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
63. Segredo V., Burford N.T., Lameh J., and Sadee W. A constitutively internalizing and recycling mutant of the Mu-opioid receptor. J. Neurochem. 68 (1997) 2395-2404
64. Shahrestanifar M., Wang W.W., and Howells R.D. Studies on inhibition of Mu and Delta opioid receptor binding by dithiothreitol and N-ethylmaleimide. His223 is critical for Mu opioid receptor binding and inactivation by N-ethylmaleimide. J. Biol. Chem 271 (1996) 5505-5512
65. Smith S.A., Stupfel J.T., Ilias N.A., and Olsen G.D. Guinea pig Mu opioid receptor: brainstem expression in the morphine-exposed neonate. Neurotoxicol. Teratol. 26 (2004) 121-129
66. Stevens C.W., Brasel C.M., and Mohan S. Cloning and bioinformatics of amphibian Mu, Delta, Kappa, and Nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals. Neurosci. Lett. 419 (2007) 189-194
67. Surratt C.K., Johnson P.S., Moriwaki A., Seidleck B.K., Blaschak C.J., Wang J.B., and Uhl G.R. Mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269 (1994) 20548-20553
68. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24 (2007) 1596-1599
69. Tanowitz M., and Von Z.M. A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J. Biol. Chem. 278 (2003) 45978-45986
70. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
71. Thompson R.C., Mansour A., Akil H., and Watson S.J. Cloning and pharmacological characterization of a rat Mu opioid receptor. Neuron 11 (1993) 903-913
72. Tiwari S., Ramachandran S., Bhattacharya A., Bhattacharya S., and Ramaswamy R. Prediction of probable genes by Fourier analysis of genomic sequences. Comput. Appl. Biosci. 13 (1997) 263-270
73. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu. Rev. Biochem. 73 (2004) 953-990
74. Walthers E.A., Bradford C.S., and Moore F.L. Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa. J. Mol. Endocrinol. 34 (2005) 247-256
75. Wang J.B., Johnson P.S., Persico A.M., Hawkins A.L., Griffin C.A., and Uhl G.R. Human Mu opiate receptor. CDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338 (1994) 217-222
76. Wang W.W., Shahrestanifar M., Jin J., and Howells R.D. Studies on Mu and Delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. USA 92 (1995) 12436-12440
77. Watson B., Meng F., and Akil H. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of Mu opioid ligands. Neurobiol. Dis. 3 (1996) 87-96
78. Wernersson R., and Pedersen A.G. RevTrans: multiple alignment of coding DNA from aligned amino acid sequences. Nucleic Acids Res. 31 (2003) 3537-3539
79. Wicht H. The brains of lampreys and hagfishes: characteristics, characters, and comparisons. Brain Behav. Evol. 48 (1996) 248-261
80. Wolf R., Koch T., Schulz S., Klutzny M., Schroder H., Raulf E., Buhling F., and Hollt V. Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat Mu opioid receptor. Mol. Pharmacol. 55 (1999) 263-268
81. Woods I.G., Wilson C., Friedlander B., Chang P., Reyes D.K., Nix R., Kelly P.D., Chu F., Postlethwait J.H., and Talbot W.S. The zebrafish gene map defines ancestral vertebrate chromosomes. Genome Res. 15 (2005) 1307-1314
82. Xue J.C., Chen C., Zhu J., Kunapuli S.P., de Riel J.K., Yu L., and Liu-Chen L.Y. The third extracellular loop of the Mu opioid receptor is important for agonist selectivity. J. Biol. Chem. 270 (1995) 12977-12979
83. Yang W., Law P.Y., Guo X., and Loh H.H. In vivo activation of a mutant Mu-opioid receptor by antagonist: future direction for opiate pain treatment paradigm that lacks undesirable side effects. Proc. Natl. Acad. Sci. USA 100 (2003) 2117-2121
84. Zhang J., and Nei M. Accuracies of ancestral amino acid sequences inferred by the parsimony, likelihood, and distance methods. J. Mol. Evol. 44 Suppl. 1 (1997) S139-S146
85. Zhang X.H., and Chasin L.A. Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons. Proc. Natl. Acad. Sci. USA 103 (2006) 13427-13432
86. Zhu X., and Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37 (1998) 15773-15784